Citations (62)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Mehri Jamilian, Fatemeh Foroozanfard, Elham Kavossian, Esmat Aghadavod, Elaheh Amirani, Mostafa Mahdavinia, Alireza Mafi & Zatollah Asemi. (2019) Carnitine and chromium co-supplementation affects mental health, hormonal, inflammatory, genetic, and oxidative stress parameters in women with polycystic ovary syndrome. Journal of Psychosomatic Obstetrics & Gynecology 0:0, pages 1-9.
Read now
Read now
Longfa Kou, Rui Sun, Vadivel Ganapathy, Qing Yao & Ruijie Chen. (2018) Recent advances in drug delivery via the organic cation/carnitine transporter 2 (OCTN2/SLC22A5). Expert Opinion on Therapeutic Targets 22:8, pages 715-726.
Read now
Read now
Hamidreza Jamilian, Mehri Jamilian, Mansooreh Samimi, Faraneh Afshar Ebrahimi, Maryam Rahimi, Fereshteh Bahmani, Sama Aghababayan, Mobina Kouhi, Sedighe Shahabbaspour & Zatollah Asemi. (2017) Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Gynecological Endocrinology 33:6, pages 442-447.
Read now
Read now
Anna Hadjihambi, Varun Khetan & Rajiv Jalan. (2014) Pharmacotherapy for hyperammonemia. Expert Opinion on Pharmacotherapy 15:12, pages 1685-1695.
Read now
Read now
Jonathan P Sturgeon & Debbie L Shawcross. (2014) Recent insights into the pathogenesis of hepatic encephalopathy and treatments. Expert Review of Gastroenterology & Hepatology 8:1, pages 83-100.
Read now
Read now
Luisa Colucci, Massimiliano Bosco, Antonio Rosario Ziello, Raffaele Rea, Francesco Amenta & Angiola Maria Fasanaro. (2012) Effectiveness of nootropic drugs with cholinergic activity in treatment of cognitive deficit: a review. Journal of Experimental Pharmacology 4, pages 163-172.
Read now
Read now
Kristian Bjøro. (2011) This month in Scandinavian Journal of Gastroenterology. Scandinavian Journal of Gastroenterology 46:6, pages 643-644.
Read now
Read now
Articles from other publishers (55)
Cuiwei He, Erwei Hao, Chengzhi Du, Wei Wei, Xiaodong Wang, Tongxiang Liu & Jiagang Deng. (2023) Investigating the Underlying Mechanisms of Ardisia japonica Extract’s Anti-Blood-Stasis Effect via Metabolomics and Network Pharmacology. Molecules 28:21, pages 7301.
Crossref
Crossref
Maija Dambrova, Marina Makrecka-Kuka, Janis Kuka, Reinis Vilskersts, Didi Nordberg, Misty M. Attwood, Stefan Smesny, Zumrut Duygu Sen, An Chi Guo, Eponine Oler, Siyang Tian, Jiamin Zheng, David S. Wishart, Edgars Liepinsh & Helgi B. Schiöth. (2022) Acylcarnitines: Nomenclature, Biomarkers, Therapeutic Potential, Drug Targets, and Clinical Trials. Pharmacological Reviews 74:3, pages 506-551.
Crossref
Crossref
Siddheesh Rajpurohit, Balaji Musunuri, Shailesh, Pooja Basthi Mohan & Shiran Shetty. (2022) Novel Drugs for the Management of Hepatic Encephalopathy: Still a Long Journey to Travel. Journal of Clinical and Experimental Hepatology 12:4, pages 1200-1214.
Crossref
Crossref
Hyunwoo Oh, Chan Hyuk Park & Dae Won Jun. (2022) Impact of l-Carnitine Supplementation on Liver Enzyme Normalization in Patients with Chronic Liver Disease: A Meta-Analysis of Randomized Trials. Journal of Personalized Medicine 12:7, pages 1053.
Crossref
Crossref
Victoria T. Kronsten, Thomas H. Tranah, Carmine Pariante & Debbie L. Shawcross. (2022) Gut-derived systemic inflammation as a driver of depression in chronic liver disease. Journal of Hepatology 76:3, pages 665-680.
Crossref
Crossref
Victoria Tatiana Kronsten & Debbie Lindsay Shawcross. (2022) Hepatic encephalopathy and depression in chronic liver disease: is the common link systemic inflammation?. Analytical Biochemistry 636, pages 114437.
Crossref
Crossref
Peng Wang, Xiaoxia Gao, Meili Liang, Yuan Fang, Jinping Jia, Junsheng Tian, Zhenyu Li & Xuemei Qin. (2021) Dose-Effect/Toxicity of Bupleuri Radix on Chronic Unpredictable Mild Stress and Normal Rats Based on Liver Metabolomics. Frontiers in Pharmacology 12.
Crossref
Crossref
Leen Z. Hasan & George Y. Wu. (2021) Novel Agents in the Management of Hepatic Encephalopathy: A Review. Journal of Clinical and Translational Hepatology 000:000, pages 000-000.
Crossref
Crossref
Farzaneh Pirmadah, Nahid Ramezani-Jolfaie, Mohammad Mohammadi, Nasir Talenezhad, Cain C. T. Clark & Amin Salehi-Abargouei. (2019) Does l-carnitine supplementation affect serum levels of enzymes mainly produced by liver? A systematic review and meta-analysis of randomized controlled clinical trials. European Journal of Nutrition 59:5, pages 1767-1783.
Crossref
Crossref
Graeme Preston, Tim Emmerzaal, Faisal Kirdar, Laura Schrader, Marloes Henckens, Eva Morava & Tamas Kozicz. (2020) Cerebellar mitochondrial dysfunction and concomitant multi-system fatty acid oxidation defects are sufficient to discriminate PTSD-like and resilient male mice. Brain, Behavior, & Immunity - Health 6, pages 100104.
Crossref
Crossref
Manuela Pennisi, Giuseppe Lanza, Mariagiovanna Cantone, Emanuele D’Amico, Francesco Fisicaro, Valentina Puglisi, Luisa Vinciguerra, Rita Bella, Enzo Vicari & Giulia Malaguarnera. (2020) Acetyl-L-Carnitine in Dementia and Other Cognitive Disorders: A Critical Update. Nutrients 12:5, pages 1389.
Crossref
Crossref
Maryam Alimirah, Omar Sadiq & Stuart C. Gordon. (2020) Novel Therapies in Hepatic Encephalopathy. Clinics in Liver Disease 24:2, pages 303-315.
Crossref
Crossref
Noah Y. Mahpour, Lauren Pioppo-Phelan, Mishal Reja, Augustine Tawadros & Vinod K. Rustgi. (2020) Pharmacologic Management of Hepatic Encephalopathy. Clinics in Liver Disease 24:2, pages 231-242.
Crossref
Crossref
. (2020) KASL clinical practice guidelines for liver cirrhosis: Varices, hepatic encephalopathy, and related complications. Clinical and Molecular Hepatology 26:2, pages 83-127.
Crossref
Crossref
Mahdod Eftekar. (2019) The association between hepatic encephalopathy/minimal hepatic encephalopathy and depressive and anxiety disorders: a systematic review. Australasian Psychiatry 28:1, pages 61-65.
Crossref
Crossref
Moein Askarpour, Kurosh Djafarian, Ehsan Ghaedi, Omid Sadeghi, Ali Sheikhi & Sakineh Shab-Bidar. (2020) Effect of L-Carnitine Supplementation on Liver Enzymes: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Archives of Medical Research 51:1, pages 82-94.
Crossref
Crossref
Cory Szybala, Mollie Parker Szybala & Peter B. Bongiorno. 2020. Textbook of Natural Medicine. Textbook of Natural Medicine
1358
1367.e4
.
Peter B. Bongiorno. 2020. Textbook of Natural Medicine. Textbook of Natural Medicine
1063
1081.e7
.
Esmaeil Yousefi Rad, Elham Eslampour, Ebrahim Falahi, Mahnaz Mardani, Azita Hekmatdoost, Omid Asbaghi & Somayeh Saboori. (2019) Effects of carnitine supplementation on liver aminotransferase enzymes: A systematic review and meta-analysis of randomized controlled clinical trials. Indian Journal of Gastroenterology 38:6, pages 470-479.
Crossref
Crossref
Michaela D. Filiou & Carmen Sandi. (2019) Anxiety and Brain Mitochondria: A Bidirectional Crosstalk. Trends in Neurosciences 42:9, pages 573-588.
Crossref
Crossref
J.A. González-Regueiro, M.F. Higuera-de la Tijera, R. Moreno-Alcántar & A. Torre. (2019) Pathophysiology of hepatic encephalopathy and future treatment options. Revista de Gastroenterología de México (English Edition) 84:2, pages 195-203.
Crossref
Crossref
J.A. González-Regueiro, M.F. Higuera-de la Tijera, R. Moreno-Alcántar & A. Torre. (2019) Fisiopatología y opciones de tratamiento a futuro en la encefalopatía hepática. Revista de Gastroenterología de México 84:2, pages 195-203.
Crossref
Crossref
Arturo J Martí-Carvajal, Christian Gluud, Ingrid Arevalo-Rodriguez & Cristina Elena Martí-Amarista. (2019) Acetyl-L-carnitine for patients with hepatic encephalopathy. Cochrane Database of Systematic Reviews 2019:1.
Crossref
Crossref
G. S. Anikin, A. A. Makhova & E. V. Shikh. (2019) Prospects of application of acetyl-L-carnitine in neurology and psychiatry (the treatment of polyneuropathy and depressive states). Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 119:8, pages 130.
Crossref
Crossref
Lorenzo Ridola, Silvia Nardelli, Stefania Gioia & Oliviero Riggio. (2018) Quality of life in patients with minimal hepatic encephalopathy. World Journal of Gastroenterology 24:48, pages 5446-5453.
Crossref
Crossref
Xiao‐Jun Cai, Lei Wang & Chun‐Mei Hu. (2018)
Retracted
: Efficacy of different drugs in the treatment of minimal hepatic encephalopathy: A network meta‐analysis involving 826 patients based on 10 randomized controlled trials
. Journal of Cellular Biochemistry 119:10, pages 8336-8345.
Crossref
Crossref
Giulia Malaguarnera, Manuela Pennisi, Gaetano Bertino, Massimo Motta, Antonio Borzì, Enzo Vicari, Rita Bella, Filippo Drago & Michele Malaguarnera. (2018) Resveratrol in Patients with Minimal Hepatic Encephalopathy. Nutrients 10:3, pages 329.
Crossref
Crossref
Nicola Veronese, Brendon Stubbs, Marco Solmi, Olesya Ajnakina, Andre F. Carvalho & Stefania Maggi. (2018) Acetyl-l-Carnitine Supplementation and the Treatment of Depressive Symptoms: A Systematic Review and Meta-Analysis. Psychosomatic Medicine 80:2, pages 154-159.
Crossref
Crossref
Xiaoxia Gao, Meili Liang, Yuan Fang, Fang Zhao, Junsheng Tian, Xiang Zhang & Xuemei Qin. (2018) Deciphering the Differential Effective and Toxic Responses of Bupleuri Radix following the Induction of Chronic Unpredictable Mild Stress and in Healthy Rats Based on Serum Metabolic Profiles. Frontiers in Pharmacology 8.
Crossref
Crossref
Akram Jamshidzadeh, Hossein Niknahad, Reza Heidari, Mahdi Zarei, Mohammad Mehdi Ommati & Forouzan Khodaei. (2017) Carnosine protects brain mitochondria under hyperammonemic conditions: Relevance to hepatic encephalopathy treatment. PharmaNutrition 5:2, pages 58-63.
Crossref
Crossref
Joel G. Hashimoto, Kristine M. Wiren & Clare J. Wilhelm. (2016) A neurotoxic alcohol exposure paradigm does not induce hepatic encephalopathy. Neurotoxicology and Teratology 56, pages 35-40.
Crossref
Crossref
Cecilia Maldonado, Natalia Guevara, Cecilia Queijo, Raquel González, Pietro Fagiolino & Marta Vázquez. (2016) Carnitine and/or Acetylcarnitine Deficiency as a Cause of Higher Levels of Ammonia. BioMed Research International 2016, pages 1-8.
Crossref
Crossref
Bonnie J. Kaplan, Julia J. Rucklidge, Amy Romijn & Kevin McLeod. (2015) The Emerging Field of Nutritional Mental Health. Clinical Psychological Science 3:6, pages 964-980.
Crossref
Crossref
Caroline Paula Mescka, Gilian Guerreiro, Bruna Donida, Desirèe Marchetti, Carlos Alberto Yasin Wayhs, Graziela Schimitt Ribas, Adriana Simon Coitinho, Moacir Wajner, Carlos Severo Dutra-Filho & Carmen Regla Vargas. (2015) Investigation of inflammatory profile in MSUD patients: benefit of L-carnitine supplementation. Metabolic Brain Disease 30:5, pages 1167-1174.
Crossref
Crossref
K. Kocsis, L. Knapp, J. Mészáros, Z. Kis, T. Farkas, L. Vécsei & J. Toldi. (2014) Acetyl-L-carnitine and oxaloacetate in post-treatment against LTP impairment in a rat ischemia model. An in vitro electrophysiological study. Journal of Neural Transmission 122:6, pages 867-872.
Crossref
Crossref
Xinyu Liu, Peng Zheng, Xinjie Zhao, Yuqing Zhang, Chunxiu Hu, Jia Li, Jieyu Zhao, Jingjing Zhou, Peng Xie & Guowang Xu. (2015) Discovery and Validation of Plasma Biomarkers for Major Depressive Disorder Classification Based on Liquid Chromatography–Mass Spectrometry. Journal of Proteome Research 14:5, pages 2322-2330.
Crossref
Crossref
Piero Amodio. 2015. Cirrhosis: A practical guide to management. Cirrhosis: A practical guide to management
105
123
.
Abeer Hassan, Yasuhiro Tsuda, Akira Asai, Keisuke Yokohama, Ken Nakamura, Tetsuya Sujishi, Hideko Ohama, Yusuke Tsuchimoto, Shinya Fukunishi, Usama M. Abdelaal, Usama A. Arafa, Ali T. Hassan, Ali M. Kassem & Kazuhide Higuchi. (2015) Effects of Oral L-Carnitine on Liver Functions after Transarterial Chemoembolization in Intermediate-Stage HCC Patients. Mediators of Inflammation 2015, pages 1-10.
Crossref
Crossref
Arturo J Martí-Carvajal, Christian Gluud & Ingrid Arevalo-Rodriguez. (2014) Acetyl-L-carnitine for patients with hepatic encephalopathy. Cochrane Database of Systematic Reviews.
Crossref
Crossref
K. Kocsis, L. Knapp, L. Gellért, G. Oláh, Zs. Kis, H. Takakuwa, N. Iwamori, E. Ono, J. Toldi & T. Farkas. (2014) Acetyl-l-carnitine normalizes the impaired long-term potentiation and spine density in a rat model of global ischemia. Neuroscience 269, pages 265-272.
Crossref
Crossref
Sheng-Min Wang, Changsu Han, Soo-Jung Lee, Ashwin A. Patkar, Prakash S. Masand & Chi-Un Pae. (2014) A review of current evidence for acetyl-l-carnitine in the treatment of depression. Journal of Psychiatric Research 53, pages 30-37.
Crossref
Crossref
Jennifer A. Frontera. (2014) Management of Hepatic Encephalopathy. Current Treatment Options in Neurology 16:6.
Crossref
Crossref
Giulia Malaguarnera, Manuela Pennisi, Caterina Gagliano, Marco Vacante, Michele Malaguarnera, Salvatore Salomone, Filippo Drago, Gaetano Bertino, Filippo Caraci, Giuseppe Nunnari & Mariano Malaguarnera. (2014) Acetyl-L-Carnitine Supplementation During HCV Therapy With Pegylated Interferon-α2b Plus Ribavirin: Effect on Work Performance. A Randomized Clinical Trial. Hepatitis Monthly 14:5.
Crossref
Crossref
Naoki Hotta. (2014) Carnitine Deficiency and Improvement of Muscle Cramp by Administration of Carnitine in Patients with Liver Cirrhosis. Open Journal of Gastroenterology 04:05, pages 242-248.
Crossref
Crossref
Takuya Adachi, Shin-ichi Fujioka, Yasuyuki Shimomura, Manri Kawakami, Toshiya Oosawa & Tatsuya Itoshima. (2014) Examination of the utility of the carnitine replacement therapy for hyperammonemia. Kanzo 55:8, pages 459-467.
Crossref
Crossref
Qian Jiang, Gang Jiang, Ke-qing Shi, Hong Cai, Yi-xin Wang & Ming-hua Zheng. (2013) Oral Acetyl-L-Carnitine treatment in hepatic encephalopathy: view of evidence-based medicine. Annals of Hepatology 12:5, pages 803-809.
Crossref
Crossref
Robert Ringseis, Janine Keller & Klaus Eder. (2013) Mechanisms underlying the anti-wasting effect of l-carnitine supplementation under pathologic conditions: evidence from experimental and clinical studies. European Journal of Nutrition 52:5, pages 1421-1442.
Crossref
Crossref
Michele Malaguarnera. (2013) Acetyl-L-carnitine in hepatic encephalopathy. Metabolic Brain Disease 28:2, pages 193-199.
Crossref
Crossref
Tanja Burkard, Annette Biedermann, Christoph Herold, Michael Dietlein, Markus Rauch & Martin Diefenbach. (2013) Treatment with a potassium–iron–phosphate–citrate complex improves PSE scores and quality of life in patients with minimal hepatic encephalopathy. European Journal of Gastroenterology & Hepatology 25:3, pages 352-358.
Crossref
Crossref
Miroslav Cuturic, Ruth K. Abramson, Robert R. Moran, James W. Hardin, Elaine M. Frank & Andrea A. Sellers. (2012) Serum carnitine levels and levocarnitine supplementation in institutionalized Huntington’s disease patients. Neurological Sciences 34:1, pages 93-98.
Crossref
Crossref
Olav B. Smeland, Tore W. Meisingset, Karin Borges & Ursula Sonnewald. (2012) Chronic acetyl-l-carnitine alters brain energy metabolism and increases noradrenaline and serotonin content in healthy mice. Neurochemistry International 61:1, pages 100-107.
Crossref
Crossref
Kakulavarapu V. Rama Rao & Michael D. Norenberg. (2012) Brain energy metabolism and mitochondrial dysfunction in acute and chronic hepatic encephalopathy. Neurochemistry International 60:7, pages 697-706.
Crossref
Crossref
Mariano Malaguarnera. (2012) Carnitine derivatives. Current Opinion in Gastroenterology 28:2, pages 166-176.
Crossref
Crossref
Giampaolo Bianchi, Marco Giovagnoli, Anna Simona Sasdelli & Giulio Marchesini. (2012) Hepatic Encephalopathy and Health-Related Quality of Life. Clinics in Liver Disease 16:1, pages 159-170.
Crossref
Crossref
Michele Malaguarnera, Marco Vacante, Massimo Motta, Maria Giordano, Giulia Malaguarnera, Rita Bella, Giuseppe Nunnari, Liborio Rampello & Giovanni Pennisi. (2011) Acetyl-L-carnitine improves cognitive functions in severe hepatic encephalopathy: a randomized and controlled clinical trial. Metabolic Brain Disease 26:4, pages 281-289.
Crossref
Crossref